COVID-19 associated thrombotic microangiopathy

被引:6
作者
Yilmaz, Esra Karabag [1 ]
Cebi, Memnune Nur [2 ]
Karahan, Iremnaz [2 ]
Saygili, Seha [1 ]
Gulmez, Ruveyda [1 ]
Demirgan, Ebru Burcu [3 ]
Durak, Cansu [4 ]
Aygun, Fatih [5 ]
Ozaltin, Fatih [6 ,7 ]
Caliskan, Salim [1 ]
Canpolat, Nur [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Paediat Nephrol, Istanbul, Turkiye
[2] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Paediat, Istanbul, Turkiye
[3] Istanbul Training & Res Hosp, Dept Paediat Nephrol, Istanbul, Turkiye
[4] Sancaktepe Sehit Prof Dr Ilhan Varank Training & R, Dept Paediat Intens Care Unit, Istanbul, Turkiye
[5] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Paediat Intens Care Unit, Istanbul, Turkiye
[6] Hacettepe Univ, Dept Pediat, Nephrogenet Lab, Sch Med, Ankara, Turkiye
[7] Hacettepe Univ, Fac Med, Dept Paediat Nephrol, Ankara, Turkiye
关键词
COVID-19; eculizumab; HUS; thrombotic microangiopathy; TMA;
D O I
10.1111/nep.14225
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A limited number of cases of thrombotic microangiopathy (TMA) have previously been reported in association with COVID-19. Our report describes two cases of TMA associated with COVID-19, one of which was successfully treated with eculizumab. The first case was a 23-month-old girl, and the second case was a 9-month-old boy. PCR tests for SARS-CoV-2 were positive in both cases, and laboratory results showed microangiopathic haemolytic anaemia, thrombocytopenia, and acute kidney injury. No known aetiology for TMA was found in either case. Stool tests for Shigatoxin-producing Escherichia coli were negative. Coagulation tests, ADAMTS13 activity, serum complement levels, and homocysteine levels were all within the normal range. No known genetic mutation was found, including mutations of complement, diacylglycerol kinase epsilon, and cobalamin C. In the first case, eculizumab was administered due to persistent haemolysis and prolonged anuria. In conclusion, TMA may be associated with COVID-19 infection. Treatment with eculizumab may be beneficial in selected patients because of the potential activation of the complement system.
引用
收藏
页码:557 / 560
页数:4
相关论文
共 22 条
[1]   Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19 [J].
Alizadeh, Faraz ;
O'Halloran, Amanda ;
Alghamdi, Areej ;
Chen, Charlotte ;
Trissal, Maria ;
Traum, Avram ;
DeCourcey, Danielle .
PEDIATRICS, 2021, 147 (02)
[2]   Eculizumab in secondary atypical haemolytic uraemic syndrome [J].
Cavero, Teresa ;
Rabasco, Cristina ;
Lopez, Antia ;
Roman, Elena ;
Avila, Ana ;
Sevillano, Angel ;
Huerta, Ana ;
Rojas-Rivera, Jorge ;
Fuentes, Carolina ;
Blasco, Miquel ;
Jarque, Ana ;
Garcia, Alba ;
Mendizabal, Santiago ;
Gavela, Eva ;
Macia, Manuel ;
Quintana, Luis F. ;
Maria Romera, Ana ;
Borrego, Josefa ;
Arjona, Emi ;
Espinosa, Mario ;
Portoles, Jose ;
Gracia-Iguacel, Carolina ;
Gonzalez-Parra, Emilio ;
Aljama, Pedro ;
Morales, Enrique ;
Cao, Mercedes ;
Rodriguez de Cordoba, Santiago ;
Praga, Manuel .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (03) :466-474
[3]   Complement activation in patients with COVID-19: A novel therapeutic target [J].
Cugno, Massimo ;
Meroni, Pier Luigi ;
Gualtierotti, Roberta ;
Griffini, Samantha ;
Grovetti, Elena ;
Torri, Adriana ;
Panigada, Mauro ;
Aliberti, Stefano ;
Blasi, Francesco ;
Tedesco, Francesco ;
Peyvandi, Flora .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (01) :215-+
[4]   Thrombotic Microangiopathy in a Severe Pediatric Case of COVID-19 [J].
Dalkiran, Tahir ;
Kandur, Yasar ;
Kara, Emine Manolya ;
Dagoglu, Besra ;
Taner, Sevgin ;
Oncu, Dogan .
CLINICAL MEDICINE INSIGHTS-PEDIATRICS, 2021, 15
[5]   Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations [J].
Diorio, Caroline ;
McNerney, Kevin O. ;
Lambert, Michele ;
Paessler, Michele ;
Anderson, Elizabeth M. ;
Henrickson, Sarah E. ;
Chase, Julie ;
Liebling, Emily J. ;
Burudpakdee, Chakkapong ;
Lee, Jessica H. ;
Balamuth, Frances B. ;
Blatz, Allison M. ;
Chiotos, Kathleen ;
Fitzgerald, Julie C. ;
Giglia, Therese M. ;
Gollomp, Kandace ;
John, Audrey R. Odom ;
Jasen, Cristina ;
Leng, Tomas ;
Petrosa, Whitney ;
Vella, Laura A. ;
Witmer, Char ;
Sullivan, Kathleen E. ;
Laskin, Benjamin L. ;
Hensley, Scott E. ;
Bassiri, Hamid ;
Behrens, Edward M. ;
Teachey, David T. .
BLOOD ADVANCES, 2020, 4 (23) :6051-6063
[6]  
Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875
[7]   Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily [J].
Gavriilaki, Eleni ;
Brodsky, Robert A. .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (06) :E227-E230
[8]   Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy [J].
Grasselli, Giacomo ;
Zangrillo, Alberto ;
Zanella, Alberto ;
Antonelli, Massimo ;
Cabrini, Luca ;
Castelli, Antonio ;
Cereda, Danilo ;
Coluccello, Antonio ;
Foti, Giuseppe ;
Fumagalli, Roberto ;
Iotti, Giorgio ;
Latronico, Nicola ;
Lorini, Luca ;
Merler, Stefano ;
Natalini, Giuseppe ;
Piatti, Alessandra ;
Ranieri, Marco Vito ;
Scandroglio, Anna Mara ;
Storti, Enrico ;
Cecconi, Maurizio ;
Pesenti, Antonio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1574-1581
[9]   Clinical Characteristics of Coronavirus Disease 2019 in China [J].
Guan, W. ;
Ni, Z. ;
Hu, Yu ;
Liang, W. ;
Ou, C. ;
He, J. ;
Liu, L. ;
Shan, H. ;
Lei, C. ;
Hui, D. S. C. ;
Du, B. ;
Li, L. ;
Zeng, G. ;
Yuen, K. -Y. ;
Chen, R. ;
Tang, C. ;
Wang, T. ;
Chen, P. ;
Xiang, J. ;
Li, S. ;
Wang, Jin-lin ;
Liang, Z. ;
Peng, Y. ;
Wei, L. ;
Liu, Y. ;
Hu, Ya-hua ;
Peng, P. ;
Wang, Jian-ming ;
Liu, J. ;
Chen, Z. ;
Li, G. ;
Zheng, Z. ;
Qiu, S. ;
Luo, J. ;
Ye, C. ;
Zhu, S. ;
Zhong, N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) :1708-1720
[10]   Neurologic Features in Severe SARS-CoV-2 Infection [J].
Helms, Julie ;
Meziani, Ferhat .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23) :2268-2270